AIDX — Healwell Al Cashflow Statement
0.000.00%
- CA$423.34m
- CA$502.82m
- CA$38.97m
- 22
- 29
- 40
- 19
Annual cashflow statement for Healwell Al, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.03 | -15.5 | -21 | -31.5 | -27.5 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.996 | 6.58 | 4.52 | 16.9 | 1.61 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.73 | -1.65 | 1.88 | 1.07 | -2.83 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 4.22 | -7.1 | -8.35 | -10.8 | -22.6 |
| Capital Expenditures | -0.234 | -2.37 | -1.17 | -0.066 | -1.31 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -6.28 | 0 | 1.42 | -14.1 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.234 | -8.64 | -1.17 | 1.35 | -15.4 |
| Financing Cash Flow Items | 0.037 | -1.98 | 4.99 | 2.03 | 0 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -4.22 | 22 | 3.78 | 27.2 | 28.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.234 | 6.25 | -5.73 | 17.8 | -9.75 |